GRADIENT CAPITAL ADVISORS, LLC – ImmunoPrecise Antibodies Ltd. Transaction History
GRADIENT CAPITAL ADVISORS, LLC portfolio value:
$107,000
portfolio value
GRADIENT CAPITAL ADVISORS, LLC quarter portfolio value change:
+5.00%
quarter
ImmunoPrecise Antibodies Ltd. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +34.04% | 6.80K shares | 31K | $3.99 | 26.80K |
| Q2 2022 | share | 0.00% | 0 shares | -27K | $3.8 | 20K | |
| Q1 2022 | share | 0.00% | 0 shares | -4K | $5.14 | 20K | |
| Q4 2021 | share | Decrease | -7.91% | -1.71K shares | -28K | $5.45 | 20K |
| Q3 2021 | share | 0.00% | 0 shares | 4K | $6.22 | 21.71K | |
| Q2 2021 | share | 0.00% | 0 shares | -82K | $6.02 | 21.71K | |
| Q1 2021 | share | 0.00% | 0 shares | -112K | $9.82 | 21.71K | |
| Q4 2020 | share | Increase | 0.00% | 21.71K shares | 325K | $14.95 | 21.71K |